Patient-reported Quality of Life Following Stereotactic Body Radiotherapy and Conventionally Fractionated External Beam Radiotherapy Compared with Active Surveillance Among Men with Localized Prostate Cancer

Dominic H. Moon, Ram S. Basak, Deborah S. Usinger, Gregg A. Dickerson, David E. Morris, Mark Perman, Maili Lim, Turner Wibbelsman, Jerry Chang, Zachary Crawford, James R. Broughman, Paul A. Godley, Ronald C. Chen

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Patients receiving stereotactic body radiotherapy for localized prostate cancer had favorable quality of life in urinary, bowel, and sexual function domains up to 2 yr following treatment, which appeared similar to men on active surveillance.

Original languageEnglish (US)
Pages (from-to)391-397
Number of pages7
JournalEuropean urology
Volume76
Issue number3
DOIs
StatePublished - Sep 2019
Externally publishedYes

Keywords

  • Active surveillance
  • External beam radiotherapy
  • Intensity-modulated radiotherapy
  • Localized prostate cancer
  • Patient-reported quality of life
  • Stereotactic body radiotherapy

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Patient-reported Quality of Life Following Stereotactic Body Radiotherapy and Conventionally Fractionated External Beam Radiotherapy Compared with Active Surveillance Among Men with Localized Prostate Cancer'. Together they form a unique fingerprint.

  • Cite this

    Moon, D. H., Basak, R. S., Usinger, D. S., Dickerson, G. A., Morris, D. E., Perman, M., Lim, M., Wibbelsman, T., Chang, J., Crawford, Z., Broughman, J. R., Godley, P. A., & Chen, R. C. (2019). Patient-reported Quality of Life Following Stereotactic Body Radiotherapy and Conventionally Fractionated External Beam Radiotherapy Compared with Active Surveillance Among Men with Localized Prostate Cancer. European urology, 76(3), 391-397. https://doi.org/10.1016/j.eururo.2019.02.026